Development of drug delivery systems to achieve site-speciˆc delivery or prolonged retention in the circulation has attracted attention, because new types of drugs are expected to be created with advances in life science and biotechnology such as the Human Genome Project. We have tried to develop a new administration route for drug targeting to the liver, since drug administration by the intravenous and oral routes makes it di‹cult to achieve a local site of action in the liver. Although direct application to the liver surface should result in local drug distribution, drug absorption from the liver surface has not been reported in the literature. Therefore we analyzed the absorption mechanism of several organic anions and dextrans with diŠerent molecular weights as model drugs, after application to the rat liver surface in vivo, employing a cylindrical diŠusion cell. Every compound appeared gradually in the plasma, followed by excretion into the bile and/or urine, indicating the possibility of drug absorption from the liver surface. A speciˆc transport system might not be involved in the absorption process from the liver surface, because the eŠect of dose and transport inhibitors on the absorption was not recognized. In addition, molecular weight was found to be a determining factor in absorption from the liver surface. The targeting e‹cacy was considerably enhanced by application to the liver surface, as compared with intravenous administration. Moreover, we have identiˆed important physicochemical and pharmaceutical factors determining the absorption rate of a drug from the liver surface for clinical use. Consequently, drug application to the liver surface could improve availability in the desired site of a new drug such as bioactive compounds and genomic medicines, by combination with appropriate chemical and pharmaceutical formulation modiˆcations.
A cylindrical diŠusion cell (i.d., 9 mm; area, 0.64 cm 2 ) made by glass was employed to selectively study the absorption of a drug from the rat liver surface. The diŠusion cell was attached to the left lateral lobe of the rat liver, using Aron Alpha biocompatible glue in the hatched region. The drug solution was added to the diŠusion cell.
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No. 8 Binding parameters (dissociation constant Kd and binding site) of Cat-BSA and Lac-BSA were obtained by in vitro association experiments using isolated rat parenchymal cells. 14, 20) The internalization rate constant kint of Cat-BSA was estimated from the relationship between the bound amount in vitro association experiment and the steady-state uptake rate in the rat liver constant infusion system. 15) The k int for Lac-BSA was obtained by EDTA-wash experiment. 20) 16, 17) 
